rs1110144

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_014141.6(CNTNAP2):​c.3475+37073G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.368 in 152,076 control chromosomes in the GnomAD database, including 11,245 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.37 ( 11245 hom., cov: 33)

Consequence

CNTNAP2
NM_014141.6 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.417

Publications

11 publications found
Variant links:
Genes affected
CNTNAP2 (HGNC:13830): (contactin associated protein 2) This gene encodes a member of the neurexin family which functions in the vertebrate nervous system as cell adhesion molecules and receptors. This protein, like other neurexin proteins, contains epidermal growth factor repeats and laminin G domains. In addition, it includes an F5/8 type C domain, discoidin/neuropilin- and fibrinogen-like domains, thrombospondin N-terminal-like domains and a putative PDZ binding site. This protein is localized at the juxtaparanodes of myelinated axons, and mediates interactions between neurons and glia during nervous system development and is also involved in localization of potassium channels within differentiating axons. This gene encompasses almost 1.5% of chromosome 7 and is one of the largest genes in the human genome. It is directly bound and regulated by forkhead box protein P2, a transcription factor related to speech and language development. This gene has been implicated in multiple neurodevelopmental disorders, including Gilles de la Tourette syndrome, schizophrenia, epilepsy, autism, ADHD and intellectual disability. [provided by RefSeq, Jul 2017]
CNTNAP2 Gene-Disease associations (from GenCC):
  • complex neurodevelopmental disorder
    Inheritance: AR, AD Classification: DEFINITIVE, NO_KNOWN Submitted by: ClinGen
  • cortical dysplasia-focal epilepsy syndrome
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE, SUPPORTIVE Submitted by: G2P, Illumina, Labcorp Genetics (formerly Invitae), Orphanet, Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.536 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014141.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
NM_014141.6
MANE Select
c.3475+37073G>A
intron
N/ANP_054860.1A0A090N7T7

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
CNTNAP2
ENST00000361727.8
TSL:1 MANE Select
c.3475+37073G>A
intron
N/AENSP00000354778.3Q9UHC6-1
CNTNAP2
ENST00000628930.2
TSL:2
c.652+37073G>A
intron
N/AENSP00000487516.1B7Z1Y6
CNTNAP2
ENST00000627772.2
TSL:2
n.1648+37073G>A
intron
N/A

Frequencies

GnomAD3 genomes
AF:
0.367
AC:
55837
AN:
151958
Hom.:
11221
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.541
Gnomad AMI
AF:
0.299
Gnomad AMR
AF:
0.273
Gnomad ASJ
AF:
0.353
Gnomad EAS
AF:
0.244
Gnomad SAS
AF:
0.402
Gnomad FIN
AF:
0.308
Gnomad MID
AF:
0.272
Gnomad NFE
AF:
0.302
Gnomad OTH
AF:
0.352
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.368
AC:
55910
AN:
152076
Hom.:
11245
Cov.:
33
AF XY:
0.366
AC XY:
27206
AN XY:
74348
show subpopulations
African (AFR)
AF:
0.541
AC:
22449
AN:
41458
American (AMR)
AF:
0.273
AC:
4176
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.353
AC:
1227
AN:
3472
East Asian (EAS)
AF:
0.244
AC:
1266
AN:
5182
South Asian (SAS)
AF:
0.402
AC:
1941
AN:
4824
European-Finnish (FIN)
AF:
0.308
AC:
3255
AN:
10556
Middle Eastern (MID)
AF:
0.293
AC:
86
AN:
294
European-Non Finnish (NFE)
AF:
0.302
AC:
20501
AN:
67974
Other (OTH)
AF:
0.349
AC:
736
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.501
Heterozygous variant carriers
0
1716
3433
5149
6866
8582
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
532
1064
1596
2128
2660
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.310
Hom.:
10133
Bravo
AF:
0.367
Asia WGS
AF:
0.362
AC:
1261
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.85
CADD
Benign
0.47
DANN
Benign
0.73
PhyloP100
-0.42
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1110144; hg19: chr7-148001291; COSMIC: COSV107474651; API